---
figid: PMC8070608__cancers-13-01838-g002
figtitle: 'Plasmin and Plasminogen System in the Tumor Microenvironment: Implications
  for Cancer Diagnosis, Prognosis, and Therapy'
organisms:
- Mus musculus
- Bos taurus
- Canis lupus familiaris
- Cricetulus griseus
- Homo sapiens
- Mouse mammary tumor virus
- Citrus macrophylla
organisms_ner:
- Mus musculus
- Canis lupus familiaris
- Homo sapiens
- Bos taurus
- Cricetulus griseus
- Danio rerio
pmcid: PMC8070608
filename: cancers-13-01838-g002.jpg
figlink: pmc/articles/PMC8070608/figure/cancers-13-01838-f002/
number: F2
caption: 'Regulation of S100A10 (p11): P11 is transactivated by (1) the promyelocytic
  leukemia-retinoic acid receptor alpha (PML-RARα) fusion oncoprotein, (2) TGFβ1-dependent
  activation of the SMAD pathway, and (3) oncogenic RAS-mediated activation of the
  Ral-GDS/Ral pathway. Conversely, transcriptional repression of P11 is mediated by
  (1) ATRA- and arsenic trioxide (AsO3)-induced degradation of the PML-RARα fusion
  oncoprotein, (2) growth factor-induction of the PI3K/mTOR pathway and consequent
  FOXC2-dependent transcriptional repression of p11, and (3) ATRA-activation of RARα.
  Newly transcribed p11 and p36 (Annexin A2) proteins rapidly form the AIIt heterotetramer
  complex within the cytoplasm prior to being transported to the cell surface. Although
  the p11–p36 interaction protects p11 from degradation by the 26S proteasome, ATRA
  and AsO3 both induced the ubiquitin-independent degradation of p11 by the 20S proteasome.
  Once at the cell surface, AIIt acts as a dual receptor for plasminogen and tissue
  plasminogen activator (tPA) and co-localizes with and urokinase-type-plasminogen
  activator/uPAR complex. By localizing plasminogen and its activators, AIIt catalyzes
  the cleavage of plasminogen to produce plasmin, a serine protease involved in ECM
  degradation, inflammation, cellular migration an invasion, and blood clot dissolution.'
papertitle: 'Plasmin and Plasminogen System in the Tumor Microenvironment: Implications
  for Cancer Diagnosis, Prognosis, and Therapy.'
reftext: Alamelu G. Bharadwaj, et al. Cancers (Basel). 2021 Apr;13(8):1838.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9648148
figid_alias: PMC8070608__F2
figtype: Figure
redirect_from: /figures/PMC8070608__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8070608__cancers-13-01838-g002.html
  '@type': Dataset
  description: 'Regulation of S100A10 (p11): P11 is transactivated by (1) the promyelocytic
    leukemia-retinoic acid receptor alpha (PML-RARα) fusion oncoprotein, (2) TGFβ1-dependent
    activation of the SMAD pathway, and (3) oncogenic RAS-mediated activation of the
    Ral-GDS/Ral pathway. Conversely, transcriptional repression of P11 is mediated
    by (1) ATRA- and arsenic trioxide (AsO3)-induced degradation of the PML-RARα fusion
    oncoprotein, (2) growth factor-induction of the PI3K/mTOR pathway and consequent
    FOXC2-dependent transcriptional repression of p11, and (3) ATRA-activation of
    RARα. Newly transcribed p11 and p36 (Annexin A2) proteins rapidly form the AIIt
    heterotetramer complex within the cytoplasm prior to being transported to the
    cell surface. Although the p11–p36 interaction protects p11 from degradation by
    the 26S proteasome, ATRA and AsO3 both induced the ubiquitin-independent degradation
    of p11 by the 20S proteasome. Once at the cell surface, AIIt acts as a dual receptor
    for plasminogen and tissue plasminogen activator (tPA) and co-localizes with and
    urokinase-type-plasminogen activator/uPAR complex. By localizing plasminogen and
    its activators, AIIt catalyzes the cleavage of plasminogen to produce plasmin,
    a serine protease involved in ECM degradation, inflammation, cellular migration
    an invasion, and blood clot dissolution.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Plg
  - Tgfb1
  - Plau
  - Prap1
  - Plaur
  - S100a10
  - Gpr162
  - ras
  - Hras
  - Kras
  - Rem1
  - Tgfbr1
  - Ralgds
  - Pik3r1
  - 20S
  - Rala
  - Shc3
  - Mtor
  - Smad2
  - Smad4
  - Pml
  - Fxyd1
  - Foxc2
  - Rara
  - Anxa2
  - Mnat1
  - Phc2
  - Nt5c3
  - Plat
  - Hadha
  - Psl1
  - Smad3
  - PLG
  - TGFB1
  - TGFBR1
  - RALGDS
  - MTOR
  - SMAD2
  - SMAD4
  - PML
  - FOXC2
  - RARA
  - S100A10
  - PLAT
  - SMAD3
  - PLAU
  - PRAP1
  - PLAUR
  - ENDOU
  - EXOSC6
  - GPR162
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - RALA
  - RALB
  - GDF1
  - RNH1
  - PPP1R13L
  - SHC3
  - ANXA2
  - NT5C3A
  - H3C9P
  - HADHA
  - plg
  - tgfb1a
  - rab1ab
  - kita
  - ngfra
  - pak2a
  - itpka
  - tgfbr1a
  - ralgds
  - mtor
  - smad2
  - smad4a
  - smad4b
  - raraa
  - smad3a
  - ATRA
  - GDP
  - Tyrosine
  - DDOD DOO
---
